Pharmacoutilization and costs of osteoarthritis: changes inducedby the introduction of a cyclooxygenase-2 inhibitor into clinicalpractice

Abstract

To establish whether the introduction of a cyclooxygenase-2 inhibitorhas led to changes in pharmacoutilization in the treatment of osteoarthritis(OA) in clinical practice.

Publication
Rheumatology (Oxford)
Gianluca Baio
Gianluca Baio
Professor of Statistics and Health Economics